In CSF samples of familiar AD patients, high Amylin concentrations are associated with decreased Aβ1-42 levels, which suggests that Amylin may influence Aβ1-42 transport between the brain, CSF, and blood [282,283]. Here, IAPP is linked to Alzheimer disease.